| Profile | GDS1873 / 201212_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 386.98 | 71 |
| GSM40788 | control - Rep 2 | 217.831 | 56 |
| GSM40789 | control - Rep 3 | 233.187 | 58 |
| GSM40775 | androgen treated - Rep 1 | 228.329 | 58 |
| GSM40776 | androgen treated - Rep 2 | 343.886 | 69 |
| GSM40777 | androgen treated - Rep 3 | 251.698 | 60 |
| GSM40790 | estrogen treated - Rep 1 | 246.408 | 60 |
| GSM40791 | estrogen treated - Rep 2 | 337.308 | 68 |
| GSM40792 | estrogen treated - Rep 3 | 374.788 | 70 |
| GSM40784 | A + tamoxifen - Rep 1 | 297.451 | 65 |
| GSM40785 | A + tamoxifen - Rep 2 | 263.709 | 62 |
| GSM40786 | A + tamoxifen - Rep 3 | 354.212 | 70 |
| GSM40778 | A + anastrozole - Rep 1 | 187.815 | 51 |
| GSM40779 | A + anastrozole - Rep 2 | 390.631 | 70 |
| GSM40780 | A + anastrozole - Rep 3 | 319.224 | 67 |
| GSM40781 | A + letrozole - Rep 1 | 165.027 | 46 |
| GSM40782 | A + letrozole - Rep 2 | 266.176 | 62 |
| GSM40783 | A + letrozole - Rep 3 | 332.311 | 68 |